• No products in the cart.

DIABNEXT

DIABNEXT INSTALLS ITS HEADQUARTERS IN PARIS TO DEVELOP ITS TELEMEDICINE OFFER

DIABNEXT is moving its headquarters to 10 rue Treilhard, in the 8th arrondissement of Paris, France in the Morning Monceau space. This implementation makes it possible to maintain close relations with key hospitals for Diabetes in Europe, and in particular to develop its telemedicine platform for healthcare professionals.

With the opening of this office, DIABNEXT wishes to grow in the French and European markets, especially with its offer for remote patient monitoring for healthcare providers. In close proximity to the major AP-HP hospitals and key players in diabetes, DIABNEXT can develop strategic partnerships and adapt its offer to the needs of healthcare professionals. While many European governments are putting in place ambitious telemedicine programs, DIABNEXT plans to develop in 2018, its platform for providers, diabetologists, nutritionists, CDEs which will facilitate the management of their cohort of diabetes patients.

In France, the Program “Etapes” provides funding for healthcare professionals and monitoring solutions for chronic diseases management including diabetes. The development of telemedicine is currently the subject of a strong political will, which is reflected in several developments:

  • The entry of remote patient monitoring acts into the common law of reimbursement by health insurance.
  • Continuation of the program  “ETAPES”  for remote patient monitoring until its reimbursement tariffs by social security is in place no later than July 1, 2019.
  • Medical telemonitoring remains in the “ETAPES” experimental setting for a period of 4 years.

To support the development of DIABNEXT in France and Europe, the team has established its office at Morning Monceau in the 8th arrondissement of Paris. The Morning spaces represent the largest startup community in France, a place of exchanges and creativity between companies.